Search

Your search keyword '"Marjolein B. Aerts"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Marjolein B. Aerts" Remove constraint Author: "Marjolein B. Aerts" Database OpenAIRE Remove constraint Database: OpenAIRE
26 results on '"Marjolein B. Aerts"'

Search Results

1. Clinical correlates of cerebral white matter abnormalities in patients with Parkinson's disease

2. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy

Catalog

Books, media, physical & digital resources

3. The difficulty of diagnosing NCSE in clinical practice; external validation of the Salzburg criteria

4. Motor neuron disease in sub-Saharan Africa: case series from a Tanzanian referral hospital

5. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism

6. Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study

7. The wrong end of the telescope: neuromuscular mimics of movement disorders (and vice versa)

8. A LRSAM1 mutation links Charcot-Marie-Tooth type 2 to Parkinson's disease

9. CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

10. Medio-Lateral Balance Impairment Differentiates between Parkinson's Disease and Atypical Parkinsonism

11. Susceptibility-Weighted Imaging Improves the Diagnostic Accuracy of 3T Brain MRI in the Work-Up of Parkinsonism

12. Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism

13. Ancillary investigations to diagnose parkinsonism: a prospective clinical study

14. Phenomenology, classification, and diagnostic approach to patients with movement disorders

15. Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias

16. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls

17. O1‐12‐06: MHPG as an additional marker for the differentiation of dementia with Lewy bodies from Alzheimer's disease, vascular dementia and frontotemporal dementia

18. Improving the diagnostic accuracy in parkinsonism: a three-pronged approach

19. O2‐01‐08: CSF Neurotransmitter Metabolites and Brain‐Specific Proteins Differentiate Dementia with Lewy Bodies from Alzheimer's

20. [Insufficient medication compliance in Parkinson's disease]

21. Diagnostic challenges in parkinsonism

22. The 'bicycle sign' for atypical parkinsonism

23. CSF Tau, Abeta42, and MHPG Differentiate Dementia with Lewy Bodies from Alzheimer's Disease

24. Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome

25. Is heart rate variability related to gait impairment in patients with Parkinson's disease? A pilot study

26. CSF α-synuclein does not differentiate between parkinsonian disorders